Predictors of achieving HbA 1c <7% and no hypoglycaemia 6 months after initiation of biphasic insulin aspart 30 in patients with type 2 diabetes in the IMPROVE study

By Valensi Paul  

Current Medical Research and Opinion, Vol. 29, Iss. 6, 2013-06 ,pp. : 601-609

Informa Healthcare

Access to resources Recommend Favorite

Transferring type 2 diabetes patients with uncontrolled glycaemia from biphasic human insulin to biphasic insulin aspart 30: experiences from the PRESENT study

By Shestakova M.   Sharma S. K.   Almustafa M.   Min K. W.   Ayad N.   Azar S. T.   Danciulescu R.   Khutsoane D.   Guler S.  

Current Medical Research and Opinion, Vol. 23, Iss. 12, 2007-12 ,pp. : 3209-3214

Informa Healthcare

Access to resources Recommend Favorite

Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study

By Wenying Yang   Benroubi Marian   Borzi Vito   Gumprecht Janusz   Kawamori Ryuzo   Shaban Joseph   Shah Siddharth   Shestakova Marina   Ligthelm Robert   Valensi Paul  

Current Medical Research and Opinion, Vol. 25, Iss. 11, 2009-11 ,pp. : 2643-2654

Informa Healthcare

Access to resources Recommend Favorite

Biphasic insulin aspart 30 as insulin initiation or replacement therapy: the China cohort of the IMPROVE study

By Yang Wenying   Gao Yan   Liu Guoliang   Chen Lulu   Fu Zuzhi   Zou Dajin   Feng Ping   Zhao Zhigang  

Current Medical Research and Opinion, Vol. 26, Iss. 1, 2010-01 ,pp. : 101-107

Informa Healthcare

Access to resources Recommend Favorite

Treat-to-target comparison between once daily biphasic insulin aspart 30 and insulin glargine in Chinese and Japanese insulin-naïve subjects with type 2 diabetes

By Yang Wenying   Xu Xiangjin   Liu Xiaomin   Yang Gangyi   Seino Yutaka   Andersen Henning   Jinnouchi Hideaki  

Current Medical Research and Opinion, Vol. 29, Iss. 12, 2013-12 ,pp. : 1599-1608

Informa Healthcare

Access to resources Recommend Favorite